Gilead Wins a Key Battle with the CDC Over Patents for Its Truvada HIV Pill

Gilead Sciences won a key round in its battle with the US government over allegations that the CDC breached several contracts and “secretly” obtained patents stemming from research that led to the groundbreaking Truvada pill for preventing HIV.